Les résultats de l’essai STOP-or-NOT publiés ce jour dans le @JAMA_current . Merci à tous les investigateurs. @matthieulegrand @APHP @INICRCT @UCSF https://t.co/e2Cetzq6RD
Among patients who underwent major noncardiac surgery, renin-angiotensin system inhibitor continuation before surgery was not associated with a higher rate of postoperative complications than discontinuation. https://t.co/Y07g8bGLyo
#ESCCongress
Here is the very first basic science paper of our lab. This is a collaborative project with McGill Univ showing an important role of circulating RNA in venous thrombosis.
Wonderful team effort!! @FCouturaud@U1304GETBO@UBO_UnivBrest@InsermGrdOuest https://t.co/5M5x6N4Js7
Pour le plaisir des couleurs. Schéma de synthèse de la Prévention de la maladie thromboembolique veineuse péri-opératoire. RFE GIHP-SFAR-SFTH-SFMV, sur https://t.co/pWt4TzpR3i
@GIHP_official@SFAR_ORG@SFTHemostase@lasfmv
Trauma resuscitation may be seen through sequential steps that occur in parallel and in series; these interventions are at both the patient and system level to optimize and individualize trauma care.
@SCHMITTJohan1#JoTACS
https://t.co/WoXVtfp30q
Quels progrès récents en traumatologie vitale ?
Une réponse dans cette revue narrative de nos camarades de l’HIA de Brest @santearmees publiée dans @JTraumAcuteSurg ! #JeunesOps
Ferric derisomaltose and tranexamic acid, combined or alone, for reducing blood transfusion in patients with hip fracture (the HiFIT trial): a multicentre, 2 × 2 factorial, randomised, double-blind, controlled trial.
https://t.co/USOb5TDqUq
Happy to share our latest paper : the HiFIT trial showing that combining treatment (Ferric derisomaltose and TXA) impoves #PBM in hip fractures @SFAR_ORG@mxmleger@EmmanuelRineau@NATAforum
https://t.co/6t7aRMhOmi
@RodgerMarc@PantepAng@SusanRKahn1@isth From behalf @INNOVTE1 network, Many thanks and congrats to you and @isth2023 organizers for this wonderful congress. By the way, huge thanks to INNOVTE members dream team,physicians, scientists, young fellows, for their major involvement in this meeting. 🙏👏👍 @FCouturaud
Whether thromboprophylaxis prevents symptomatic venous thromboembolism in medically ill, hospitalized older adults remains debated. In this #RCT, older adults hospitalized for acute medical conditions were randomized to receive daily enoxaparin or placebo.
#ISTH2023#VTE
Landmark SYMPTOMS randomized trial in VTE prevention in older patients presented by Gregoire Le Gal @grelegal on behalf Dominique Mottier, Karine Lacut and @INNOVTE1 network, @u1304GETBO , #ISTH
Postpartum haemorrhage (#PPH) is a major cause for maternal mortality and difficult to predict. @DeMoreuil shows interesting data on impaired pre-delivery thrombin generation but more research is needed to better identify women at risk. 🩸🤰📈 #ISTH2023